Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 2Phase 3 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 10Unknown 8Terminated 4Recruiting 4Active not recruiting 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Pancreatic Neoplasms 4Urachal cancer 1Rectal Neoplasms 1Neoplasms 1Carcinoma, Hepatocellular 1Borderline Resectable Pancreatic Cancer 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 2 × Unknown × folfirinox × Clear all
NCT05868317 2023-05-22

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

Salah Azaïz Cancer Institute

Phase 2 Unknown
70 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01676259 2021-07-02

PROTACT

Silenseed Ltd

Phase 2 Unknown
80 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT01591733 2021-05-28

FOLFIRINOX + RT for Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
48 enrolled 16 charts
Gastrointestinal

Pancreatic Neoplasms

NCT04611724 2020-11-02

A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

Asan Medical Center

Phase 2 Unknown
35 enrolled

Urachal cancer

NCT01821729 2020-09-25

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Massachusetts General Hospital

Phase 2 Unknown
50 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT02717091 2020-09-10

Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer

Nagoya University

Phase 2 Unknown
50 enrolled
Gastrointestinal

Borderline Resectable Pancreatic Cancer

NCT03812783 2019-01-23

HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC

Sun Yat-sen University

Phase 2 Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02862015 2017-10-31

Oncothermia

Seoul National University Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡